Reply to Baird and Douglas

Affiliations

¹ Julius Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
² P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium.
³ Brown University and Providence Veterans Administration Hospital, Providence, Rhode Island, USA.
⁴ Bacterial Vaccine Discovery and Early Development, Janssen Vaccines and Prevention B. V., Leiden, The Netherlands.

Comment

Marc Bonten et al. Clin Infect Dis. 2021.

. 2021 May 4;72(9):e436.

doi: 10.1093/cid/ciaa1106.

¹ Julius Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
² P95 Pharmacovigilance and Epidemiology Services, Leuven, Belgium.
³ Brown University and Providence Veterans Administration Hospital, Providence, Rhode Island, USA.
⁴ Bacterial Vaccine Discovery and Early Development, Janssen Vaccines and Prevention B. V., Leiden, The Netherlands.

No abstract available

Comment in

Re: Epidemiology of Escherichia coli Bacteraemia: A Systematic Literature Review.
Baird RW, Douglas NM. Baird RW, et al. Clin Infect Dis. 2021 May 4;72(9):e435. doi: 10.1093/cid/ciaa1105. Clin Infect Dis. 2021. PMID: 32756968 No abstract available.

Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review.
Bonten M, Johnson JR, van den Biggelaar AHJ, Georgalis L, Geurtsen J, de Palacios PI, Gravenstein S, Verstraeten T, Hermans P, Poolman JT. Bonten M, et al. Clin Infect Dis. 2021 Apr 8;72(7):1211-1219. doi: 10.1093/cid/ciaa210. Clin Infect Dis. 2021. PMID: 32406495
Re: Epidemiology of Escherichia coli Bacteraemia: A Systematic Literature Review.
Baird RW, Douglas NM. Baird RW, et al. Clin Infect Dis. 2021 May 4;72(9):e435. doi: 10.1093/cid/ciaa1105. Clin Infect Dis. 2021. PMID: 32756968 No abstract available.